BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  White Paper Examines Early Clinical Development of B-Cell Depletion Therapies in Autoimmune Disease

  July 30, 2026

   · 

  3 min read
• Press Releases

  Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results

  July 30, 2026

   · 

  13 min read
• Press Releases

  Verdiva Bio Initiates Phase 1 Study of VRB-103, a Selective Oral Amylin Peptide Analog With Weekly Dosing Potential

  July 30, 2026

   · 

  3 min read
• Press Releases

  Crescent Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights

  July 30, 2026

   · 

  12 min read
• Press Releases

  Vericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Share Repurchase Program

  July 30, 2026

   · 

  13 min read
• Press Releases

  SIGA to Host Business Update Call on August 6, 2026, Following Release of Second-Quarter 2026 Financial Results

  July 30, 2026

   · 

  1 min read
• Press Releases

  Wave Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update

  July 30, 2026

   · 

  15 min read
• Press Releases

  Tvardi Therapeutics Selects Ulcerative Colitis as Initial Indication for TTI-109

  July 30, 2026

   · 

  9 min read
• Press Releases

  InflaRx to Report Second Quarter 2026 Results on August 6, 2026

  July 30, 2026

   · 

  2 min read
• Press Releases

  Palvella Therapeutics Chief Scientific Officer Jeff Martini, Ph.D. Selected to Present at Upcoming FDA Public Workshop on Drug Repurposing

  July 30, 2026

   · 

  8 min read